Want to create an interactive transcript for this episode?
Podcast: Share Talk LTD
Episode: Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals (HEMO.L) Interview
Description:
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce its participation at the H.C. Wainwright Global Life Sciences Conference. The Company will be featured as a presenting company. The conference will be held on a virtual platform from March 9-10, 2021.
As part of the Company's presentation, Dr. Vladislav Sandler, CEO of Hemogenyx Pharmaceuticals, will provide an overview of the Company's business and product candidates.
If you are an institutional investor, and would like to listen to the Company's presentation, please click on the following...